π Neuland Labs Hits 9-Month High with Strong Buying Momentum
Neuland Laboratories (
NEULANDLAB
) surged 5.07% on 11 Sept 2025, closing at βΉ15,554, its highest level in nine months and surpassing a key resistance to mark a Calendar Year 2025 high of βΉ15,760. The rally was driven by strong buying momentum. Despite short-term earnings pressure, the consistently high institutional holding in Neuland Labs signals trust in its long-term business outlook.
Snapshot:
β’ Market Cap: βΉ18,526 Cr | Category: Small Cap
β’ 52W Range: βΉ10,190 β βΉ18,100
β’ PE: 104.99 vs Sector PE: 26.71
β’ P/B: 12.13 | Div. Yield: 0.08%
β’ ROE: 17.06% | ROCE: 16.23% | EPS: 10.77
Neuland Labs is a leading manufacturer of APIs and end-to-end chemistry solutions for global pharma companies, with capabilities spanning from compound synthesis to commercial launches.
π Disclaimer:
This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.